STRS Ohio’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-24,300
| Closed | -$807K | – | 2112 |
|
|
2022
Q4 | $807K | Sell |
24,300
-2,300
| -9% | -$74.1K | ﹤0.01% | 1035 |
|
|
2022
Q3 | $838K | Buy |
26,600
+10,100
| +61% | +$327K | ﹤0.01% | 999 |
|
|
2022
Q2 | $501K | Buy |
16,500
+1,000
| +6% | +$27K | ﹤0.01% | 1350 |
|
|
2022
Q1 | $402K | Buy |
+15,500
| New | +$369K | ﹤0.01% | 1524 |
|
|
2021
Q2 | – | Sell |
-15,100
| Closed | -$396K | – | 2490 |
|
|
2021
Q1 | $396K | Sell |
15,100
-22,600
| -60% | -$537K | ﹤0.01% | 1646 |
|
|
2020
Q4 | $704K | Hold |
37,700
| – | – | ﹤0.01% | 1272 |
|
|
2020
Q3 | $640K | Buy |
37,700
+2,900
| +8% | +$56.4K | ﹤0.01% | 1190 |
|
|
2020
Q2 | $810K | Buy |
+34,800
| New | +$504K | ﹤0.01% | 999 |
|
|
2016
Q1 | – | Sell |
-1,100
| Closed | -$21.7K | – | 1942 |
|
|
2015
Q4 | $22K | Hold |
1,100
| – | – | ﹤0.01% | 1850 |
|
|
2015
Q3 | $18K | Buy |
+1,100
| New | +$20.1K | ﹤0.01% | 1830 |
|
|
2014
Q2 | – | Sell |
-30,135
| Closed | -$657K | – | 1781 |
|
|
2014
Q1 | $657K | Sell |
30,135
-10,265
| -25% | -$235K | ﹤0.01% | 1030 |
|
|
2013
Q4 | $1.07M | Sell |
40,400
-8,300
| -17% | -$204K | ﹤0.01% | 708 |
|
|
2013
Q3 | $1.15M | Sell |
48,700
-600
| -1% | -$14K | 0.01% | 744 |
|
|
2013
Q2 | $1.06M | Buy |
+49,300
| New | +$1.06M | ﹤0.01% | 810 |
|
Other funds holding VIVO
STRS Ohio's VIVO Position: Q1 2023 in Review
STRS Ohio sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 24,300 shares — an estimated $807K sold.
STRS Ohio first reported a position in VIVO in Q2 2013 and held it in 14 quarters. The position peaked at $1.15M in Q3 2013. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.
- STRS Ohio reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
- STRS Ohio sold 24,300 Meridian Bioscience Inc shares in Q1 2023, an estimated $807K.
- STRS Ohio first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 14 quarters.
- STRS Ohio's Meridian Bioscience Inc position peaked at $1.15M in Q3 2013.
- 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.
Based on STRS Ohio's 13F filing for Q1 2023, filed 27 Apr 2023.